Latest market price
32.25
+1.88+6.19%
MAZEQT46Maze Therapeutics, Inc.·NASDAQ
32.25+6.19%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 20264Statement of changes in beneficial ownership
Oct 16, 20268-KCurrent report
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 01, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 2026144Notice of proposed sale of restricted securities
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 02, 2026144Notice of proposed sale of restricted securities
Sep 02, 2026144Notice of proposed sale of restricted securities
Sep 02, 2026144Notice of proposed sale of restricted securities
Sep 02, 2026144Notice of proposed sale of restricted securities
Sep 01, 2026144Notice of proposed sale of restricted securities
Aug 31, 20264Statement of changes in beneficial ownership
Aug 17, 20268-KCurrent report
Aug 17, 20264Statement of changes in beneficial ownership
Aug 17, 20263Initial statement of beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership